T2B Tag: BIO

Communications in biopharma–and beyond–is undergoing a transformational shift right now.

Our function is moving away from “comms” towards strategic corporate affairs, with advising on and communicating decisions that drive a company forward now being recognized as twin necessities.

Corporate affairs is a pivotal partner in achieving business success. And if it’s not at your organization or with your clients, it should be!

Edelman reported last fall that “comms leaders are increasingly informing and advising the enterprise on strategy,” with “more than half surveyed [who] consider themselves to be a strategic advisor or partner.”

Although we may not see this put into practice across biopharma yet, especially among early- and mid-stage companies, it’s time for us to challenge conventional preconceptions and embrace critical business advisory and decision-making roles in our orgs.

A few tangible examples of what this looks like day-to-day: Job titles evolving to reflect the more holistic “corporate affairs” nature of our roles.

Not asking to be on the leadership team, and once you’re there, having clear expectations set from the top down on how the C-suite should partner with and consult your function.

Internal business partners fishing for themselves, so to speak, while consulting you on campaign approach without expecting you to simply write their emails.

What experiences have you had, and what are you proactively doing to become an even more strategic communicator?

You’ve got this! Follow along with us at Ticket to Biotech to access new resources this year to support your professional growth, regardless if you’re just starting out or are a seasoned communicator.